289 related articles for article (PubMed ID: 32668278)
1. Immunohistochemical distinction of paragangliomas from epithelial neuroendocrine tumors-gangliocytic duodenal and cauda equina paragangliomas align with epithelial neuroendocrine tumors.
Mamilla D; Manukyan I; Fetsch PA; Pacak K; Miettinen M
Hum Pathol; 2020 Sep; 103():72-82. PubMed ID: 32668278
[TBL] [Abstract][Full Text] [Related]
2. Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas.
Mete O; Asa SL; Gill AJ; Kimura N; de Krijger RR; Tischler A
Endocr Pathol; 2022 Mar; 33(1):90-114. PubMed ID: 35285002
[TBL] [Abstract][Full Text] [Related]
3. Cauda Equina Neuroendocrine Tumors: Distinct Epithelial Neuroendocrine Neoplasms of Spinal Origin.
Asa SL; Mete O; Schüller U; Ramani B; Mirchia K; Perry A
Am J Surg Pathol; 2023 Apr; 47(4):469-475. PubMed ID: 36543154
[TBL] [Abstract][Full Text] [Related]
4. SDH-B, INSM1, and GATA3 expression in cauda equina neuroendocrine tumors: report on 21 cases from a North indian tertiary care center.
Sood R; Chatterjee D; Bhardwaj S; Singla N; Ahuja C; Radotra B
Hum Pathol; 2023 Jul; 137():18-24. PubMed ID: 37100233
[TBL] [Abstract][Full Text] [Related]
5. The immunohistochemical, DNA methylation, and chromosomal copy number profile of cauda equina paraganglioma is distinct from extra-spinal paraganglioma.
Ramani B; Gupta R; Wu J; Barreto J; Bollen AW; Tihan T; Mummaneni PV; Ames C; Clark A; Oberheim Bush NA; Butowski N; Phillips D; King BE; Bator SM; Treynor EC; Zherebitskiy V; Quinn PS; Walker JB; Pekmezci M; Sullivan DV; Hofmann JW; Sloan EA; M Chang S; Berger MS; Solomon DA; Perry A
Acta Neuropathol; 2020 Dec; 140(6):907-917. PubMed ID: 32892244
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of CNS paragangliomas identifies cauda equina paragangliomas as a distinct tumor entity.
Schweizer L; Thierfelder F; Thomas C; Soschinski P; Suwala A; Stichel D; Wefers AK; Wessels L; Misch M; Kim HY; Jödicke R; Teichmann D; Kaul D; Kahn J; Bockmayr M; Hasselblatt M; Younsi A; Unterberg A; Knie B; Walter J; Al Safatli D; May SA; Jödicke A; Ntoulias G; Moskopp D; Vajkoczy P; Heppner FL; Capper D; Hartmann W; Hartmann C; von Deimling A; Reuss DE; Schöler A; Koch A
Acta Neuropathol; 2020 Dec; 140(6):893-906. PubMed ID: 32926213
[TBL] [Abstract][Full Text] [Related]
7. Cauda equina neuroendocrine tumors show biological features distinct from other paragangliomas and visceral neuroendocrine tumors.
Soukup J; Manethova M; Kohout A; Soukup T; Dvorakova R; Drugda J; Vitovcova B; Gabalec F; Kaiser M; Kanta M; Kasparova P; Kozak J; Michnova L; Netuka D; Reguli S; Rychly B; Trnkova M; Vachata P; Wozniakova M; Cesak T
Virchows Arch; 2023 Feb; 482(2):325-338. PubMed ID: 36348031
[TBL] [Abstract][Full Text] [Related]
8. PHOX2B is a Sensitive and Specific Marker for the Histopathological Diagnosis of Pheochromocytoma and Paraganglioma.
Miyauchi M; Akashi T; Furukawa A; Uchida K; Tamura T; Ando N; Kirimura S; Shintaku H; Yamamoto K; Ito T; Miura K; Kayamori K; Ariizumi Y; Asakage T; Kudo A; Tanabe M; Fujii Y; Ishibashi H; Okubo K; Murakami M; Yamada T; Takemoto A; Bae Y; Eishi Y; Ohashi K
Endocr Pathol; 2022 Dec; 33(4):506-518. PubMed ID: 36029394
[TBL] [Abstract][Full Text] [Related]
9. Paraganglioma of the cauda equina: A clinicopathologic study of 12 cases with demonstration of cytokeratin positivity.
Zhang Y; Du Z; Xiong J; Wang Y; Yin B
Ann Diagn Pathol; 2022 Apr; 57():151887. PubMed ID: 35033938
[TBL] [Abstract][Full Text] [Related]
10. A rare case of multiple paragangliomas in the head and neck, retroperitoneum and duodenum: A case report and review of the literature.
Kawanabe S; Katabami T; Oshima R; Yanagisawa N; Sone M; Kimura N
Front Endocrinol (Lausanne); 2022; 13():1054468. PubMed ID: 36704041
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary gangliocytic paraganglioma: An under-recognized mimic of carcinoid tumor.
Naso JR; Wang D; Romero AO; Leclair T; Smit P; Boland JM; Folpe AL; Bois MC
Hum Pathol; 2024 Apr; 146():23-27. PubMed ID: 38442781
[TBL] [Abstract][Full Text] [Related]
12. The Diagnostic Dilemma of GATA3 Immunohistochemistry in Pheochromocytoma and Paraganglioma.
Kimura N; Shiga K; Kaneko K; Sugisawa C; Katabami T; Naruse M
Endocr Pathol; 2020 Jun; 31(2):95-100. PubMed ID: 32303954
[TBL] [Abstract][Full Text] [Related]
13. [Paraganglioma of the cauda equina].
Rickert CH; Probst-Cousin S; Schumacher HW; Gullotta F
Pathologe; 1997 Nov; 18(6):484-7. PubMed ID: 9451740
[TBL] [Abstract][Full Text] [Related]
14. Cytokeratins expression in paragangliomas of the cauda equina.
Labrousse F; Leboutet MJ; Petit B; Paraf F; Boncoeur-Martel MP; Moreau JJ; Catanzano G
Clin Neuropathol; 1999; 18(4):208-13. PubMed ID: 10442464
[TBL] [Abstract][Full Text] [Related]
15. Paragangliomas of the cauda equina. Report of one case and review of the literature.
Caruso R; Wierzbicki V; Marrocco L; Salvati M
J Exp Clin Cancer Res; 2006 Jun; 25(2):269-75. PubMed ID: 16918140
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical Expression of Choline Acetyltransferase and Catecholamine-Synthesizing Enzymes in Head-and-Neck and Thoracoabdominal Paragangliomas and Pheochromocytomas.
Kimura N; Shiga K; Kaneko KI; Oki Y; Sugisawa C; Saito J; Tawara S; Akahori H; Sogabe S; Yamashita T; Takekoshi K; Naruse M; Katabami T
Endocr Pathol; 2021 Dec; 32(4):442-451. PubMed ID: 34743284
[TBL] [Abstract][Full Text] [Related]
17. Paraganglioma of the cauda equina: an ultrastructural and immunohistochemical study of two cases.
Hirose T; Sano T; Mori K; Kagawa N; Sakaki A; Kuwamura Y; Hizawa K
Ultrastruct Pathol; 1988; 12(2):235-43. PubMed ID: 3363684
[TBL] [Abstract][Full Text] [Related]
18. [Paraganglioma of the cauda equina region: Report of 9 cases].
Seidou F; Tamarit C; Sevestre H
Ann Pathol; 2020 Nov; 40(6):436-441. PubMed ID: 32331813
[TBL] [Abstract][Full Text] [Related]
19. Pitx2 is a useful marker of midgut-derived neuroendocrine tumours - an immunohistochemical study of 224 cases.
Soukup J; Manethova M; Faistova H; Krbal L; Vitovcova B; Hornychova H; Drugda J; Cesak T; Netuka D; Gabalec F; Ryska A
Histopathology; 2022 Dec; 81(6):799-807. PubMed ID: 36089904
[TBL] [Abstract][Full Text] [Related]
20. Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms.
Rindi G; Mete O; Uccella S; Basturk O; La Rosa S; Brosens LAA; Ezzat S; de Herder WW; Klimstra DS; Papotti M; Asa SL
Endocr Pathol; 2022 Mar; 33(1):115-154. PubMed ID: 35294740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
